Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
A TOUGHER stance in the UK on funding expensive medicines for rare diseases is raising questions about the government's pledges to support a life-sciences industry that's already rattled by Brexit.
A proposal to introduce a cap on coverage of treatments within the state-run...